Co-Diagnostics
CODX
10 hedge funds and large institutions have $827K invested in Co-Diagnostics in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 3 closing their positions.
0.01% more ownership
Funds ownership: 0.17% → 0.18% (+0.01%)
0% more funds holding
Funds holding: 10 → 10 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
8% less capital invested
Capital invested by funds: $898K → $827K (-$71K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$36.9K |
| 2 |
Renaissance Technologies
New York
|
+$15.7K |
| 3 |
Barclays
London,
United Kingdom
|
+$13.6K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$5.25K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
+$1.98K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$21K |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
-$2K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Vanguard Group
Malvern,
Pennsylvania
| $529K | – | – | – |
|
|
2
HighTower Advisors
Chicago,
Illinois
| $118K | +$1.98K | +67 | +2% |
|
|
3
Barclays
London,
United Kingdom
| $78K | +$13.6K | +460 | +19% |
|
4
Geode Capital Management
Boston,
Massachusetts
| $43K | – | – | – |
|
|
VF
5
Virtu Financial
New York
| $34K | +$36.9K | +1,250 | New |
|
|
6
Renaissance Technologies
New York
| $14K | +$15.7K | +534 | New |
|
7
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| $4K | – | – | – |
|
|
8
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $4K | +$5.25K | +178 | New |
|
|
AG
9
Advisor Group
Phoenix,
Arizona
| $3K | – | – | – |
|
|
10
Citadel Advisors
Miami,
Florida
| – | -$21K | -680 | Closed |
|
|
11
Victory Capital Management
San Antonio,
Texas
| – | -$2K | -55 | Closed |
|
|
12
UBS Group
Zurich,
Switzerland
| – | -$1K | -23 | Closed |
|
|
GRP
13
Global Retirement Partners
San Rafael,
California
| – | +$88 | +3 | +50% |
|
CODX Hedge Fund Activity: Q4 2019 in Review
10 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Co-Diagnostics (CODX) for Q4 2019, worth a combined $827K — down 7.9% from $898K a quarter earlier.
Fund positioning in CODX was balanced in Q4 2019: 3 funds opened new positions, 3 closed out, 3 added to existing stakes and 0 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $36.9K. The largest seller was Citadel Advisors, exiting entirely with an estimated $21K sold.
- 10 institutional investors held Co-Diagnostics (CODX) as of Q4 2019, unchanged from Q3 2019.
- Funds reported $827K of Co-Diagnostics stock for Q4 2019, down 7.9% quarter-over-quarter.
- 3 funds opened new Co-Diagnostics positions in Q4 2019 and 3 closed out, a net change of 0 holders.
- The largest Co-Diagnostics buyer in Q4 2019 was Virtu Financial, an estimated $36.9K added.
- The largest Co-Diagnostics seller in Q4 2019 was Citadel Advisors, an estimated $21K sold.
Based on aggregated 13F filings for Q4 2019.